Vasostrict (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Vasostrict drug offered from Par Pharmaceutical, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: Vasopressin
SUBSTANCE NAME: VASOPRESSIN, UNSPECIFIED
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-11-12
END MARKETING DATE: 0000-00-00


Vasostrict HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVasostrict from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20([USP’U]/mL)
START MARKETING DATE: 2014-11-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42023-164_b2ac1cfb-772b-43e4-961b-1f8e33c77661
PRODUCT NDC: 42023-164
APPLICATION NUMBER: NDA204485

Other VASOPRESSIN, UNSPECIFIED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Par Pharmaceutical, Inc.Vasostrict